Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Persistence of Intramuscular High Dose Recombinant Hepatitis B Vaccine in Methadone Maintenance Treatment Patients in China: a Randomized Controlled Trial

NCT02991599 is registered in ClinicalTrials.gov with Shanxi Medical University as lead sponsor.

NCT NCT02991599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02991599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Persistence of Intramuscular High Dose Recombinant Hepatitis B Vaccine in Methadone Maintenance Treatment Patients in China: a Randomized Controlled Trial
Lead sponsor
Shanxi Medical University
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2014
Completion date
May 31, 2018
Enrollment
196 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b vaccine